PTGER4 and cardiac hypertrophy: Global deletion of Ep4 increases infarct size post MI/R21, whereas cardiomyocyte-specific Ep4 deletion reduces cardiac hypertrophy without changing infarct size in a model of sustained MI22, suggesting the potential involvement of cells other than cardiomyocytes in mediating the impact of global Ep4 KO.